Acasti Pharma Inc (ACST)
2.97
+0.12
(+4.21%)
USD |
NASDAQ |
May 02, 11:37
Acasti Pharma EBITDA Margin (Quarterly)
EBITDA Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBITDA Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| November 30, 2016 | -- |
| August 31, 2016 | -- |
| May 31, 2016 | -- |
| February 29, 2016 | -- |
| Date | Value |
|---|---|
| November 30, 2015 | -- |
| August 31, 2015 | -- |
| May 31, 2015 | -- |
| February 28, 2015 | -- |
| November 30, 2014 | -- |
| August 31, 2014 | -- |
| May 31, 2014 | -- |
| February 28, 2014 | -- |
| November 30, 2013 | -- |
| August 31, 2013 | -- |
| May 31, 2013 | -- |
| February 28, 2013 | -- |
| November 30, 2012 | -- |
| August 31, 2012 | -- |
| May 31, 2012 | -- |
| February 29, 2012 | -- |
| November 30, 2011 | -- |
| August 31, 2011 | -- |
| May 31, 2011 | -- |
| February 28, 2011 | -- |
EBITDA Margin Definition
EBITDA Margin (TTM) is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.